Centre prohibits selling Coronil as COVID-19 cure

▴ centre-prohibits-selling-coronil-covid19-cure
Ayush ministry has only given the approval to sell this specific formulation as an immunity booster and not as a medicinal remedy for COVID-19.

The Union ministry has banned Patanjali from selling Coronil as a cure for COVID-19.

Ayush ministry has only given the approval to sell this specific formulation as an immunity booster and not as a medicinal remedy for COVID-19, it said.  At a press conference in Haridwar, Ramdev insisted the ministry has said that Patanjali did an appropriate job for COVID-19 management.

 However, on Wednesday Yoga guru Ramdev's Patanjali Ayurved stated that there are no Ayush ministry constraints on selling 'Coronil', a drug the company recently inaugurated as medicine for COVID-19 but is now calling it a product to regulate the disease.

"I want to tell people who want to try these medicines that there is no restriction on their sale now and they will be available in a kit everywhere in the country from today," he added, citing Coronil and the two other products Patanjali is promoting together.

Ramdev told the Union ministry had asked him to use the term 'COVID-19 management' in place of 'COVID-19 treatment' and he is obeying the instruction.

Even while backtracking on characterizing Coronil as a treatment for COVID-19, the company stuck to its statement that the drug's examination on mild to moderately ill patients was successful.

Its press note said the examination, conducted after the necessary permissions, showed 100 percent recovery of patients under seven days.

It started that the Ayush ministry has categorically decided that Patanjali had suitably worked on COVID-19 management.

Now there is no disparity of opinion between Ayush ministry and Patanjali, it added.

According to the ministry, Patanjali is authorized to manufacture and dispense its Diva Coronil tablet, Divya Swasari Vati and Divya Anu Talia across India, as per the manufacturing licences awarded by State Licensing Authority, Ayurvedic and Unani Services, Govt of Uttarakhand, it said.

The Uttarakhand department was among the agencies which had challenged Patanjali's claim to have formulated a drug to cure COVID-19. It said the company had only been given a license to produce an immunity booster

Tags : #Coronil #Patanjali #COVID-19

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

10 PCOS Warning Signs That Need Your AttentionDecember 27, 2024
Experts Dub 2024 as the Year of Technologies and Innovations in Healthcare; Stress on further Integration of Technologies December 27, 2024
Aakash Healthcare Partners with Japan for Groundbreaking Surgical Intervention: A Global Collaboration to Revolutionize Cardiovascular CareDecember 26, 2024
Traditional Medicine Goes Global: How Ayush 2024 Reimagined WellnessDecember 26, 2024
Aster Guardians Global Nursing Award 2025 worth INR 2 Crore now open for nominations worldwide December 26, 2024
Holiday Season Round the Corner? 6 Daily Habits That Could Be The Reason Behind Your Fatty LiverDecember 26, 2024
Healing the Nation: Doctors as Architects of a Healthier FutureDecember 26, 2024
Brewing Health Benefits: Can Coffee and Tea Help Fight Head and Neck Cancers?December 26, 2024
Seven-Year-Old Fights Back Against Rare Autoimmune DiseaseDecember 26, 2024
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive YearDecember 26, 2024
American Oncology Institute (AOI) in Nagpur Restores Mobility with KyphoplastyDecember 26, 2024
Sanjeevani Healthcare & Wellness Expo 2024: A Dynamic Platform for Global Healthcare CollaborationDecember 23, 2024
Ranitidine: Saviour or Suspect? The Truth Behind the Stomach Acid RemedyDecember 23, 2024
From One-Size-Fits-All to Precision Medicine: The New Hope for Rare Bone Cancer PatientsDecember 23, 2024
World Meditation Day: India’s Gift of Peace to a Chaotic WorldDecember 23, 2024
Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and TreatmentDecember 23, 2024
Black Angels remind us of centuries of injustices plaguing the TB responseDecember 20, 2024
Healthcare Startups to Watch Out for in 2025December 20, 2024
Biobank Blueprint: Redefining Diabetes Diagnosis and Treatment in IndiaDecember 20, 2024
The Future of Malaria Prevention: Can This Vaccine Eliminate the Disease?December 20, 2024